BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17251467)

  • 1. Improvement in conduction velocity after optic neuritis measured with the multifocal VEP.
    Yang EB; Hood DC; Rodarte C; Zhang X; Odel JG; Behrens MM
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):692-8. PubMed ID: 17251467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal loss and myelin in early ON loss in postacute optic neuritis.
    Klistorner A; Arvind H; Nguyen T; Garrick R; Paine M; Graham S; O'Day J; Grigg J; Billson F; Yiannikas C
    Ann Neurol; 2008 Sep; 64(3):325-31. PubMed ID: 18825673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis.
    Samsen P; Chuenkongkaew WL; Masayaanon P; Chirapapaisan N; Ruangvaravate N; Loket S
    J Med Assoc Thai; 2007 Feb; 90(2):313-8. PubMed ID: 17375637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological evidence for heterogeneity of lesions in optic neuritis.
    Klistorner A; Graham S; Fraser C; Garrick R; Nguyen T; Paine M; O'Day J; Grigg J; Arvind H; Billson FA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4549-56. PubMed ID: 17898277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis.
    Alshuaib WB
    Electromyogr Clin Neurophysiol; 2000 Jun; 40(4):243-52. PubMed ID: 10907603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis.
    Fraser C; Klistorner A; Graham S; Garrick R; Billson F; Grigg J
    Arch Neurol; 2006 Jun; 63(6):847-50. PubMed ID: 16769865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual evoked potentials during hyperthermia.
    Saul RF; Hayat G; Selhorst JB
    J Neuroophthalmol; 1995 Jun; 15(2):70-8. PubMed ID: 7550932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of VEP components in optic neuritis.
    Andersson T; Sidén A
    Electromyogr Clin Neurophysiol; 1995 Mar; 35(2):77-85. PubMed ID: 7781577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of visual evoked potentials in optic neuritis.
    Heinrichs IH; McLean DR
    Can J Neurol Sci; 1988 Nov; 15(4):394-6. PubMed ID: 3208223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fellow eye changes in optic neuritis correlate with the risk of multiple sclerosis.
    Klistorner A; Arvind H; Nguyen T; Garrick R; Paine M; Graham S; Yiannikas C
    Mult Scler; 2009 Aug; 15(8):928-32. PubMed ID: 19498018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the multifocal visual evoked potential (mfVEP) latency in understanding optic nerve and retinal diseases.
    Hood DC; Chen JY; Yang EB; Rodarte C; Wenick AS; Grippo TM; Odel JG; Ritch R
    Trans Am Ophthalmol Soc; 2006; 104():71-7. PubMed ID: 17471327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous recording of pattern electroretinogram (PERG) and visual evoked potential (VEP) in multiple sclerosis.
    Stefano E; Cupini LM; Rizzo P; Pierelli F; Rizzo PA
    Acta Neurol Belg; 1991; 91(1):20-8. PubMed ID: 2028736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationship of optical coherence tomography and multifocal visual-evoked potentials after optic neuritis.
    Klistorner A; Arvind H; Garrick R; Graham SL; Paine M; Yiannikas C
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2770-7. PubMed ID: 20042660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latency of multifocal visual evoked potentials in nonoptic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions.
    Alshowaeir D; Yiannikas C; Garrick R; Parratt J; Barnett MH; Graham SL; Klistorner A
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3758-64. PubMed ID: 24833744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pattern reversal VEP and computer perimetry of the partner eye in optic neuritis].
    Lowitzsch K; Welkoborsky HJ
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1987 Dec; 18(4):179-84. PubMed ID: 3123195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.
    Henderson AP; Altmann DR; Trip AS; Kallis C; Jones SJ; Schlottmann PG; Garway-Heath DF; Plant GT; Miller DH
    Brain; 2010 Sep; 133(9):2592-602. PubMed ID: 20566483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in visual evoked potential latencies following retrobulbar neuritis].
    Gruber H
    Klin Monbl Augenheilkd; 1990 Jul; 197(1):18-9. PubMed ID: 2395298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis.
    Kolbe S; Chapman C; Nguyen T; Bajraszewski C; Johnston L; Kean M; Mitchell P; Paine M; Butzkueven H; Kilpatrick T; Egan G
    Neuroimage; 2009 Apr; 45(3):679-86. PubMed ID: 19162205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency.
    Niklas A; Sebraoui H; Hess E; Wagner A; Then Bergh F
    Mult Scler; 2009 Jan; 15(1):68-74. PubMed ID: 18701569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VISTECH contrast sensitivity and pattern-VEP in multiple sclerosis patients.
    Augustinus B; Van den Bergh L; Zeyen T
    Bull Soc Belge Ophtalmol; 1990; 236():89-96. PubMed ID: 2093410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.